Search research articles
Contact Us
Filters
Showing results (271-280 of 281) with videos related to
Page
of 29
Sort By:
The Journal of Clinical Investigation
|
May 20, 2014
Targeting CD137 enhances the efficacy of cetuximab
Holbrook E Kohrt, A Dimitrios Colevas, Roch Houot, et al.
Cancer Discovery
|
March 4, 2021
A Burned-Out CD8<sup>+</sup> T-cell Subset Expands in the Tumor Microenvironment and Curbs Cancer Immunotherapy
Miguel F Sanmamed, Xinxin Nie, Shruti S Desai, et al.
Science Translational Medicine
|
July 29, 2021
Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy
Yi Sun, Wei Chen, Robert J Torphy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2019
Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis
Ila Datar, Miguel F Sanmamed, Jun Wang, et al.
Science Immunology
|
April 26, 2024
Up-regulated PLA2G10 in cancer impairs T cell infiltration to dampen immunity
Tianxiang Zhang, Weiwei Yu, Xiaoxiao Cheng, et al.
The Journal of Clinical Investigation
|
December 7, 2023
PD-1H/VISTA mediates immune evasion in acute myeloid leukemia
Tae Kon Kim, Xue Han, Qianni Hu, et al.
Cell
|
July 5, 2024
Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance
Jiali Yu, Yijian Yan, Shasha Li, et al.
Nature Communications
|
October 29, 2014
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
Limo Chen, Don L Gibbons, Sangeeta Goswami, et al.
The New England Journal of Medicine
|
June 5, 2012
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
Suzanne L Topalian, F Stephen Hodi, Julie R Brahmer, et al.
Nature Immunology
|
June 5, 2019
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression
Qingsong Hu, Youqiong Ye, Li-Chuan Chan, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 281) with videos related to
Sort By:
Page
of 29
The Journal of Clinical Investigation
|
May 20, 2014
Targeting CD137 enhances the efficacy of cetuximab
Holbrook E Kohrt, A Dimitrios Colevas, Roch Houot, et al.
Cancer Discovery
|
March 4, 2021
A Burned-Out CD8<sup>+</sup> T-cell Subset Expands in the Tumor Microenvironment and Curbs Cancer Immunotherapy
Miguel F Sanmamed, Xinxin Nie, Shruti S Desai, et al.
Science Translational Medicine
|
July 29, 2021
Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy
Yi Sun, Wei Chen, Robert J Torphy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2019
Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis
Ila Datar, Miguel F Sanmamed, Jun Wang, et al.
Science Immunology
|
April 26, 2024
Up-regulated PLA2G10 in cancer impairs T cell infiltration to dampen immunity
Tianxiang Zhang, Weiwei Yu, Xiaoxiao Cheng, et al.
The Journal of Clinical Investigation
|
December 7, 2023
PD-1H/VISTA mediates immune evasion in acute myeloid leukemia
Tae Kon Kim, Xue Han, Qianni Hu, et al.
Cell
|
July 5, 2024
Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance
Jiali Yu, Yijian Yan, Shasha Li, et al.
Nature Communications
|
October 29, 2014
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
Limo Chen, Don L Gibbons, Sangeeta Goswami, et al.
The New England Journal of Medicine
|
June 5, 2012
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
Suzanne L Topalian, F Stephen Hodi, Julie R Brahmer, et al.
Nature Immunology
|
June 5, 2019
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression
Qingsong Hu, Youqiong Ye, Li-Chuan Chan, et al.
Page
of 29